213 related articles for article (PubMed ID: 33800912)
21. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.
Reisdorf P; Lawrence DA; Sivan V; Klising E; Martin MT
Am J Pathol; 2001 Jul; 159(1):263-72. PubMed ID: 11438473
[TBL] [Abstract][Full Text] [Related]
22. Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-αVβ6/TGF-β Signaling Cascade.
Schinner C; Xu L; Franz H; Zimmermann A; Wanuske MT; Rathod M; Hanns P; Geier F; Pelczar P; Liang Y; Lorenz V; Stüdle C; Maly PI; Kauferstein S; Beckmann BM; Sheikh F; Kuster GM; Spindler V
Circulation; 2022 Nov; 146(21):1610-1626. PubMed ID: 36268721
[TBL] [Abstract][Full Text] [Related]
23. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors.
Xiu L; Chang N; Yang L; Liu X; Yang L; Ge J; Li L
Am J Pathol; 2015 Feb; 185(2):387-98. PubMed ID: 25432063
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.
Huang S; Chen B; Su Y; Alex L; Humeres C; Shinde AV; Conway SJ; Frangogiannis NG
J Mol Cell Cardiol; 2019 Jul; 132():84-97. PubMed ID: 31085202
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis.
Yang L; Chang N; Liu X; Han Z; Zhu T; Li C; Yang L; Li L
Am J Pathol; 2012 Jul; 181(1):85-97. PubMed ID: 22609227
[TBL] [Abstract][Full Text] [Related]
27. Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis.
Lippi M; Maione AS; Chiesa M; Perrucci GL; Iengo L; Sattin T; Cencioni C; Savoia M; Zeiher AM; Tundo F; Tondo C; Pompilio G; Sommariva E
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373166
[TBL] [Abstract][Full Text] [Related]
28. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
[TBL] [Abstract][Full Text] [Related]
29. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
30. MRTF-A controls myofibroblastic differentiation of human multipotent stromal cells and their tumour-supporting function in xenograft models.
Werner S; Lützkendorf J; Müller T; Müller LP; Posern G
Sci Rep; 2019 Aug; 9(1):11725. PubMed ID: 31409840
[TBL] [Abstract][Full Text] [Related]
31. GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.
Volani C; Pagliaro A; Rainer J; Paglia G; Porro B; Stadiotti I; Foco L; Cogliati E; Paolin A; Lagrasta C; Frati C; Corradini E; Falco A; Matzinger T; Picard A; Ermon B; Piazza S; De Bortoli M; Tondo C; Philippe R; Medici A; Lavdas AA; Blumer MJF; Pompilio G; Sommariva E; Pramstaller PP; Troppmair J; Meraviglia V; Rossini A
J Cell Mol Med; 2022 Jul; 26(13):3687-3701. PubMed ID: 35712781
[TBL] [Abstract][Full Text] [Related]
32. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.
Miles C; Finocchiaro G; Papadakis M; Gray B; Westaby J; Ensam B; Basu J; Parry-Williams G; Papatheodorou E; Paterson C; Malhotra A; Robertus JL; Ware JS; Cook SA; Asimaki A; Witney A; Ster IC; Tome M; Sharma S; Behr ER; Sheppard MN
Circulation; 2019 Apr; 139(15):1786-1797. PubMed ID: 30700137
[TBL] [Abstract][Full Text] [Related]
33. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
34. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
[TBL] [Abstract][Full Text] [Related]
35. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
36. MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.
Sommariva E; D'Alessandra Y; Farina FM; Casella M; Cattaneo F; Catto V; Chiesa M; Stadiotti I; Brambilla S; Dello Russo A; Carbucicchio C; Vettor G; Riggio D; Sandri MT; Barbuti A; Vernillo G; Muratori M; Dal Ferro M; Sinagra G; Moimas S; Giacca M; Colombo GI; Pompilio G; Tondo C
Sci Rep; 2017 Jul; 7(1):4802. PubMed ID: 28684747
[TBL] [Abstract][Full Text] [Related]
37. ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway.
Yuan Q; Cao S; Dong Q; Wang Z; Xu Y; Han Q; Ma J; Wei S; Pang J; Yang F; Zhang R; Liu B; Dai S; Xue L; Wang J; Xue M; Xu T; Zheng W; Xu F; Chen Y; Guo P
J Cardiovasc Pharmacol; 2019 Apr; 73(4):248-256. PubMed ID: 30801261
[TBL] [Abstract][Full Text] [Related]
38. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
39. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway.
Hu J; Chen Y; Huang Y; Su Y
Exp Mol Pathol; 2020 Aug; 115():104468. PubMed ID: 32445750
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
